CVS Health joins list of healthcare companies aiming to make gene therapy accessible through employer
According to a recent white paper, the US-based firm plans to spread the high cost of gene therapy for its members following its 2018 acquisition of Aetna. CVS Health also plans to launch a new insurance product in March to absorb the financial risk of covering these therapies. It joins two other healthcare companies in the US developing ways to mitigate the cost of gene therapy for employees. In September last year, Cigna added a programme where members pay by month to access a feature...
The impact of Covid-19 on access to GP consultations
Part One: PMI evolution
Launch of Vitality at Work Enterprise
Entries open for intermediaries
For ill health, disability or injury